← FDA Drug Approvals (Drugs@FDA)

PAZOPANIB HYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NOVUGEN · Approved 2024-04-23

Drug application

FDA Application #

ANDA218231

Application type

Abbreviated New Drug Application (Generic)

Brand name

PAZOPANIB HYDROCHLORIDE

Generic name

PAZOPANIB HYDROCHLORIDE

Active ingredients

PAZOPANIB HYDROCHLORIDE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

NOVUGEN

Manufacturer

Novugen Pharma (USA) LLC.

First approval

2024-04-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown